Highbridge Capital Management’s Checkpoint Therapeutics CKPT Stock Holding History

Highbridge Capital Management’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,831,741	Closed	-$15.5M	–	293
2025 Q1	$15.5M	Buy	+3,831,741	New	+$12.8M	0.63%	46

Highbridge Capital Management's CKPT Position: Q2 2025 in Review

Highbridge Capital Management sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 3,831,741 shares — an estimated $15.5M sold.

Highbridge Capital Management first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $15.5M in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Highbridge Capital Management reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Highbridge Capital Management sold 3,831,741 Checkpoint Therapeutics shares in Q2 2025, an estimated $15.5M.
Highbridge Capital Management first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Highbridge Capital Management's Checkpoint Therapeutics position peaked at $15.5M in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Highbridge Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.